Union Drug Co Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 24-10-2024
- Paid Up Capital ₹ 1.05 M
as on 24-10-2024
- Company Age 99 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.18 Cr
as on 24-10-2024
- Revenue 11.24%
(FY 2023)
- Profit 11.39%
(FY 2023)
- Ebitda 0.93%
(FY 2023)
- Net Worth 2.37%
(FY 2023)
- Total Assets 1.25%
(FY 2023)
About Union Drug Co
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.05 M.
The company currently has active open charges totaling ₹1.18 Cr.
Sreeparna Bhattacharya, Bijnan Bhattacharjee, Pratima Bhattacharya, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232WB1925PLC005030
- Company No.
005030
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
26 Mar 1925
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Union Drug Co?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreeparna Bhattacharya  | Whole-Time Director | 01-Nov-2011 | Current |
| Bijnan Bhattacharjee | Director | 22-Mar-2002 | Current |
| Pratima Bhattacharya | Director | 29-Oct-2019 | Current |
| Aloke Banerjee | Director | 07-Sep-2020 | Current |
Financial of Union Drug Co.
Union Drug Co Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 11.24% increase. The company also saw a substantial improvement in profitability, with a 11.39% increase in profit. The company's net worth moved up by a moderate rise of 2.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Union Drug Co?
In 2023, Union Drug Co had a promoter holding of 74.25% and a public holding of 25.75%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pratima Securities Pvt LtdActive 18 years 6 monthsSreeparna Bhattacharya and Pratima Bhattacharya are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Mar 2014 | ₹1.18 Cr | Open |
How Many Employees Work at Union Drug Co?
Union Drug Co has a workforce of 45 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Union Drug Co, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Union Drug Co's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
